111 related articles for article (PubMed ID: 11380489)
1. Prevalence of diabetes and impaired glucose tolerance in adult hypopituitarism on low dose oral hydrocortisone replacement therapy.
McConnell EM; Bell PM; Hadden DR; McCance DR; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2001 May; 54(5):593-9. PubMed ID: 11380489
[TBL] [Abstract][Full Text] [Related]
2. Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults.
al-Shoumer KA; Beshyah SA; Niththyananthan R; Johnston DG
Clin Endocrinol (Oxf); 1995 Jan; 42(1):85-90. PubMed ID: 7889636
[TBL] [Abstract][Full Text] [Related]
3. Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism.
McConnell EM; Bell PM; Ennis C; Hadden DR; McCance DR; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2002 Feb; 56(2):195-201. PubMed ID: 11874410
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of type II diabetes mellitus in population of Krakow].
Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism.
Dunne FP; Elliot P; Gammage MD; Stallard T; Ryan T; Sheppard MC; Stewart PM
Clin Endocrinol (Oxf); 1995 Nov; 43(5):623-9. PubMed ID: 8548948
[TBL] [Abstract][Full Text] [Related]
6. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism.
DeVile CJ; Stanhope R
Clin Endocrinol (Oxf); 1997 Jul; 47(1):37-41. PubMed ID: 9302370
[TBL] [Abstract][Full Text] [Related]
7. Beta-cell function in hypopituitary adults before and during growth hormone treatment.
Beshyah SA; Gelding SV; Andres C; Johnston DG; Gray IP
Clin Sci (Lond); 1995 Sep; 89(3):321-8. PubMed ID: 7493430
[TBL] [Abstract][Full Text] [Related]
8. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
Agha A; Liew A; Finucane F; Baker L; O'Kelly P; Tormey W; Thompson CJ
Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
[TBL] [Abstract][Full Text] [Related]
9. Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.
Mortimer CH; Tunbridge WM; Carr D; Yeomans L; Lind T; Coy DH; Bloom SR; Kastin A; Mallinson CN; Besser GM; Schally AV; Hall R
Lancet; 1974 Apr; 1(7860):697-701. PubMed ID: 4132421
[No Abstract] [Full Text] [Related]
10. Low-dose hydrocortisone replacement is associated with improved arterial stiffness index and blood pressure dynamics in severely adrenocorticotrophin-deficient hypopituitary male patients.
Behan LA; Carmody D; Rogers B; Hannon MJ; Davenport C; Tormey W; Smith D; Thompson CJ; Stanton A; Agha A
Eur J Endocrinol; 2016 Jun; 174(6):791-9. PubMed ID: 27025241
[TBL] [Abstract][Full Text] [Related]
11. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.
Weaver JU; Thaventhiran L; Noonan K; Burrin JM; Taylor NF; Norman MR; Monson JP
Clin Endocrinol (Oxf); 1994 Nov; 41(5):639-48. PubMed ID: 7828353
[TBL] [Abstract][Full Text] [Related]
12. Serum glucose, insulin and C-peptide response to oral glucose after intravenous administration of hydrocortisone and methylprednisolone in man.
Bruno A; Carucci P; Cassader M; Cavallo-Perin P; Gruden G; Olivetti C; Pagano G
Eur J Clin Pharmacol; 1994; 46(5):411-5. PubMed ID: 7957534
[TBL] [Abstract][Full Text] [Related]
13. Prolonged hypocortisolemia in hydrocortisone replacement regimens in adrenocorticotrophic hormone deficiency.
Maguire AM; Ambler GR; Moore B; McLean M; Falleti MG; Cowell CT
Pediatrics; 2007 Jul; 120(1):e164-71. PubMed ID: 17576782
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of abnormal circadian blood pressure regulation and impaired glucose tolerance in adults with hypopituitarism.
Krzyzanowska K; Schnack C; Mittermayer F; Kopp HP; Hofer M; Kann T; Schernthaner G
Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):430-4. PubMed ID: 16151976
[TBL] [Abstract][Full Text] [Related]
15. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
McConnell EM; Atkinson AB; Ennis C; Hadden DR; McCance DR; Sheridan B; Bell PM
J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703
[TBL] [Abstract][Full Text] [Related]
16. Hydrocortisone replacement dosage influences intraocular pressure in patients with primary and secondary hypocortisolism.
Li Voon Chong JS; Sen J; Johnson Z; Kyle G; MacFarlane IA
Clin Endocrinol (Oxf); 2001 Feb; 54(2):267-71. PubMed ID: 11207643
[TBL] [Abstract][Full Text] [Related]
17. Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism.
Al-Shoumer KA; Ali K; Anyaoku V; Niththyananthan R; Johnston DG
Clin Endocrinol (Oxf); 1996 Aug; 45(2):171-8. PubMed ID: 8881449
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid replacement therapy and fibrinolysis in patients with hypopituitarism.
Peacey SR; Wright D; Aye M; Moisey R
Clin Endocrinol (Oxf); 2012 Jul; 77(1):94-8. PubMed ID: 22151005
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Syndrome in Hypopituitarism.
Miljić D; Popovic V
Front Horm Res; 2018; 49():1-19. PubMed ID: 29895033
[TBL] [Abstract][Full Text] [Related]
20. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
Drake WM; Coyte D; Camacho-Hübner C; Jivanji NM; Kaltsas G; Wood DF; Trainer PJ; Grossman AB; Besser GM; Monson JP
J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
